Document is current

Article History

Received: 25 April 2025

Accepted: 1 March 2026

First Online: 17 March 2026

Declarations

:

: Institutional board review was obtained for this retrospective review (IRB202202649) from the institutional board review at the University of Florida. Peter Iafrate, the IRB Chairman from the University of Florida approved the methods used to collect data included in this study. This study was approved as secondary research for which consent is not required: Secondary research use of identifiable private information or identifiable biospecimens, if at least one of the following criteria is met: the research involves only information collection and analysis involving the investigator's use of identifiable health information when that use is regulated under 45 CFR parts 160 and 164, subparts A and E, for the purposes of “health care operations” or “research” as those terms are defined at 45 CFR 164.501 or for “public health activities and purposes” as described under 45 CFR 164.512(b).

: All authors listed on this manuscript consent to publication. There are no identifying images, personal, or clinical details presented in this manuscript that compromise anonymity of those involved or studied.

: The authors declare no competing interests.